Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-07 Sale |
2023-06-09 4:25 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer |
9,273 | $12.03 | $111,526 | 60,118 (Direct) |
View |
| 2023-06-06 Sale |
2023-06-07 4:55 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer |
1,200 | $12.04 | $14,448 | 69,391 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 4:18 pm |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
250,000 | $16 | $4,000,000 | 3,315,739 (Indirect Direct) |
View |
| 2022-06-13 Purchase |
2022-06-15 6:15 pm |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
149,161 | $12.73 | $1,898,820 | 412,604 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-07 4:37 pm |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) |
View |
| 2022-06-03 Sale |
2022-06-07 4:36 pm |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) |
View |
| 2022-06-03 Sale |
2022-06-07 4:32 pm |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
750,000 | $12.25 | $9,188,775 | 1,263,593 (Indirect Direct) |
View |
| 2022-06-02 Purchase |
2022-06-06 6:14 pm |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,836,958 | $11.9 | $21,859,329 | 406,436 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-20 6:09 pm |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
420,000 | $8.5 | $3,570,000 | 313,357 (Direct) |
View |
| 2022-03-15 Sale |
2022-03-16 4:04 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
533 | $11.3 | $6,023 | 46,041 (Direct) |
View |
| 2022-01-19 Purchase |
2022-01-21 5:12 pm |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
997,961 | $14.1 | $14,071,250 | 307,627 (Direct) |
View |
| 2021-11-16 Purchase |
2021-11-18 5:00 pm |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
7,500 | $28.08 | $210,600 | 7,500 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 7:46 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
20,000 | $27.33 | $546,613 | 533 (Direct) |
View |
| 2021-09-03 Sale |
2021-09-08 6:29 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
8,084 | $33.99 | $274,794 | 96,190 (Indirect) |
View |
| 2021-09-03 Sale |
2021-09-08 6:18 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
8,084 | $33.99 | $274,794 | 96,190 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-30 Option Award |
2023-02-01 9:46 pm |
N/A 2033-01-29 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer |
121,650 | $0 | 167,691 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 9:45 pm |
N/A 2033-01-29 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
145,700 | $0 | 295,213 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 9:44 pm |
N/A 2033-01-29 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
422,750 | $0 | 523,343 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 9:44 pm |
N/A 2033-01-29 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
135,580 | $0 | 141,737 (Direct) |
View |
| 2022-12-29 Other |
2023-01-03 4:38 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
468,099 | $0 | 2,823,613 (Indirect) |
View |
| 2022-12-20 Exercise |
2022-12-20 8:05 pm |
N/A 2029-05-01 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
48,507 | $0 | 305,179 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-20 8:05 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
51 | $2.425 | 305,179 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-20 8:05 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
48,456 | $2.062 | 305,179 (Direct) |
View |
| 2022-06-06 Other |
2022-06-07 4:37 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
992,305 | $0 | 1,233,615 (Indirect) |
View |
| 2022-06-06 Other |
2022-06-07 4:36 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
992,305 | $0 | 1,233,615 (Indirect) |
View |
| 2022-06-06 Other |
2022-06-07 4:32 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
1,001,406 | $0 | 1,263,593 (Indirect) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:31 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:30 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:29 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:27 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:26 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:25 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:24 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:23 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-01-21 Exercise(A) |
2022-01-24 4:55 pm |
N/A 2032-01-20 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:45 pm |
N/A 2032-01-17 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:43 pm |
N/A 2032-01-17 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:42 pm |
N/A 2032-01-17 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:40 pm |
N/A 2032-01-17 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-10 4:43 pm |
N/A 2029-05-01 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
48,511 | $0 | 305,179 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-10 4:43 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
51 | $2.425 | 305,179 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-10 4:43 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
48,460 | $2.062 | 305,179 (Direct) |
View |
| 2021-11-23 Exercise |
2021-12-06 4:47 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
15,978 | $1.637 | 219,827 (Direct) |
View |
| 2021-11-23 Exercise |
2021-12-06 4:47 pm |
N/A 2027-06-14 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
46,041 | $0 | 219,827 (Direct) |
View |
| 2021-11-23 Exercise |
2021-12-06 4:47 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
10,473 | $2.425 | 219,827 (Direct) |
View |
| 2021-11-23 Exercise |
2021-12-06 4:47 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
19,590 | $2.062 | 219,827 (Direct) |
View |
Ownership |
2021-11-08 6:12 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 4,751,853 (Direct) |
View |
| 2021-09-07 Option Award |
2021-09-09 5:06 pm |
N/A 2031-09-07 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
42,000 | $0 | 42,000 (Direct) |
View |